BioHealth News Archive
Cartesian Therapeutics Initiates Clinical Trial of First RNA-Engineered Cell Therapy for Acute Respiratory Distress Syndrome and COVID-19 – Cartesian
Gaithersburg, MD, September 1, 2020 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for cancer, autoimmune diseases and…
Read MoreOxiWear rushes to get wearable oxygen monitor to Covid-19 patients – Washington Business Journal
OxiWear's own founder is a user herself of its oxygen monitor for patients with severe pulmonary hypertension. Image: Shavini Fernando is founder and CEO…
Read More
Economic Alliance of Greater Baltimore (EAGB), President and CEO, Michele L. Whelley, Joins Rich Bendis on BioTalk
Economic Alliance of Greater Baltimore (EAGB), President and CEO, Michele L. Whelley, joins BioTalk to discuss her career, the economic development environment in Baltimore,…
Read More
Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine | Novavax Inc. – IR Site
GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases,…
Read More
Hampton Roads accelerator program goes virtual amid pandemic – The Virginian-Pilot – Inside Business
Imagine being able to use science to choose the right music for an advertising campaign or being able to order food and groceries on…
Read More
REGENXBIO Announces FDA Clearance of IND for Phase II Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery | BioSpace
ROCKVILLE, Md., Aug. 25, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential…
Read More
Arcellx Announces EvansMDS Grant Awarded for Collaboration with Johns Hopkins and University of Colorado Researchers to Support Development of Arcellx ARC-sparX Platform Candidate ACLX-002
GAITHERSBURG, Md., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Arcellx today announced the award of an EvansMDS Discovery Research Grant to Johns Hopkins University to…
Read MoreCrisis innovators: How 5 local companies are addressing the pandemic head-on – DC Inno
Coronavirus made 2020 the year of the pivot. But the D.C.-area ventures having real, direct impact on the Covid-19 crisis have done more than…
Read More
Catalent to make drug substance for AstraZeneca’s COVID-19 vaccine candidate – Reuters
(Reuters) - Catalent Inc said on Monday its Maryland facility would make the drug substance used in the COVID-19 vaccine being developed by AstraZeneca…
Read More
Alexandria Real Estate Equities pays $590.4 million for huge portion of Parmer RTP – Triangle Business Journal
A huge portion of a campus in Research Triangle Park has been sold in a deal that tops $590 million. {iframe}https://www.bizjournals.com/triangle/news/2020/08/25/parmer-rtp-sells-253-acres-in-590-million.html{/iframe}
Read More
J.P. Morgan on the state of life sciences and strategies to fuel innovation – MedCity News
In an interview, Peter Meath, J.P. Morgan’s co-head of Healthcare and Life Sciences, Middle Market Banking & Specialized Industries, says the Covid-19 pandemic has…
Read More
Qiagen to launch digital, portable test for COVID-19 antibodies, preordering 900K for U.S. | FierceBiotech
Qiagen has announced plans to launch a new digital test for COVID-19 antibodies that can run multiple samples at once on a small portable…
Read More
OS Therapies to develop BlinkBio next-generation Antibody Drug Conjugate (ADC) technology; BlinkBio CEO Colin Goddard joins OS Therapies Board | BioSpace
CAMBRIDGE, Md. and LONDON, Aug. 26, 2020 (GLOBE NEWSWIRE) -- OS Therapies, and late-stage clinical research biotechnology company focused on Osteosarcoma and other solid…
Read More
Emergent BioSolutions Announces Appointment of Marvin White to the Company’s Board of Directors NYSE:EBS
GAITHERSBURG, Md., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company’s board of directors appointed Marvin L. White…
Read More
Genomic Analysis Suggests Some Endangered Species May Be at High Risk of SARS-CoV-2
Humans are not the only species facing a potential threat from SARS-CoV-2, according to the results of a study by an international scientific team…
Read More